Show simple item record

dc.contributor.authorKrols, Krist'l
dc.contributor.authorVan den Broeke, Maud
dc.date.accessioned2017-12-02T14:52:15Z
dc.date.available2017-12-02T14:52:15Z
dc.date.issued2011
dc.identifier.urihttp://hdl.handle.net/20.500.12127/4694
dc.description.abstractIn this article, we empirically investigate the industry determinants of value creation through Mergers and Acquisitions (M&A) and the division of M&A gains for a sample of horizontal acquisitions in Europe during the period 1997–2008. We calculate the combined abnormal return around deal announcement to proxy for M&A value creation. Our results show that industry sales concentration and the ratio of the combined target and bidder size relative to the minimum efficient scale in the corresponding industry are significantly negatively associated with M&A value creation. The relation between industry sales growth and M&A gains is U-shaped. The extent of foreign competition within the industry, industry technological intensity and industry deregulation bear no significant association with M&A wealth effects, however. Finally, the data reveal that the division of M&A gains between target and bidder investors is determined by firm and deal characteristics rather than by industry conditions.
dc.language.isoen
dc.publisherHealthcare Supply Chain Research Network
dc.subjectOperations & Supply Chain Management
dc.titleRapport over samenwerking in de healthcare supply chain
dc.source.numberofpages27
vlerick.knowledgedomainOperations & Supply Chain Management
vlerick.knowledgedomainSpecial Industries : Healthcare Management
vlerick.supervisor
vlerick.vlerickdepartmentTOM
dc.identifier.vperid35882
dc.identifier.vperid121022
dc.identifier.vpubid5587


This item appears in the following Collection(s)

Show simple item record